IR BioSciences Holdings Inc New (CE) News - IRBS | Aktien OTCMarkets

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

- Annual Report (10-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x Annual...

- Notification that Quarterly Report will be submitted late (NT 10-Q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE...

- Notification that Annual Report will be submitted late (NT 10-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING...

- Current report filing (8-K)

UN ITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT...

- Quarterly Report (10-Q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to...

- Notification that Quarterly Report will be submitted late (NT 10-Q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE...

ImmuneRegen BioSciences(R) Reports Positive Results in Cancer Vaccine Studies in Radboud University Collaboration

SCOTTSDALE, Ariz., Oct. 28, 2010 (GLOBE NEWSWIRE) -- ImmuneRegen BioSciences, Inc.®, a wholly owned subsidiary of IR BioSciences Holdings, Inc...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT...

ImmuneRegen BioSciences(R) Reports Scancell Collaboration Yielding Positive Results in Cancer Vaccine Studies of Homspera(R)

SCOTTSDALE, Ariz., Sept. 8, 2010 (GLOBE NEWSWIRE) -- ImmuneRegen BioSciences, Inc.®, a wholly owned subsidiary of IR BioSciences Holdings, Inc...

ImmuneRegen BioSciences(R) Invited to Submit Full Proposal to BARDA for Homspera(R) as a Potential Medical Countermeasure for In

SCOTTSDALE, Ariz., Aug. 31, 2010 (GLOBE NEWSWIRE) -- ImmuneRegen BioSciences®, a wholly owned subsidiary of IR Biosciences Holdings Inc...

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

IR BioSciences Holdings Inc New (CE) (IRBS)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

IRBS Nachrichten

- Annual Report (10-K)

- Notification that Quarterly Report will be submitted late (NT 10-Q)

- Notification that Annual Report will be submitted late (NT 10-K)

- Current report filing (8-K)

- Quarterly Report (10-Q)

- Notification that Quarterly Report will be submitted late (NT 10-Q)

ImmuneRegen BioSciences(R) Reports Positive Results in Cancer Vaccine Studies in Radboud University Collaboration

- Current report filing (8-K)

ImmuneRegen BioSciences(R) Reports Scancell Collaboration Yielding Positive Results in Cancer Vaccine Studies of Homspera(R)

ImmuneRegen BioSciences(R) Invited to Submit Full Proposal to BARDA for Homspera(R) as a Potential Medical Countermeasure for In

University of Rochester Medical Center Receives $15 Million in Government Funding to Research ImmuneRegen's Homspera(R)

- Quarterly Report (10-Q)

- Notification that Quarterly Report will be submitted late (NT 10-Q)

- Current report filing (8-K)

- Quarterly Report (10-Q)

IRBS Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

IR BioSciences Holdings Inc New (CE) (IRBS) News

IR BioSciences Holdings Inc New (CE) (IRBS)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

IRBS Nachrichten

- Annual Report (10-K)

- Notification that Quarterly Report will be submitted late (NT 10-Q)

- Notification that Annual Report will be submitted late (NT 10-K)

- Current report filing (8-K)

- Quarterly Report (10-Q)

- Notification that Quarterly Report will be submitted late (NT 10-Q)

ImmuneRegen BioSciences(R) Reports Positive Results in Cancer Vaccine Studies in Radboud University Collaboration

- Current report filing (8-K)

ImmuneRegen BioSciences(R) Reports Scancell Collaboration Yielding Positive Results in Cancer Vaccine Studies of Homspera(R)

ImmuneRegen BioSciences(R) Invited to Submit Full Proposal to BARDA for Homspera(R) as a Potential Medical Countermeasure for In

University of Rochester Medical Center Receives $15 Million in Government Funding to Research ImmuneRegen's Homspera(R)

- Quarterly Report (10-Q)

- Notification that Quarterly Report will be submitted late (NT 10-Q)

- Current report filing (8-K)

- Quarterly Report (10-Q)

IRBS Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen